logo

ITCI Stock: Exploring Intra-Cellular Therapies Inc’s Growth

Intra-Cellular Therapies Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $84.89 on 10/30/24, while the lowest price for the same period was registered at $45.50 on 10/31/23.

52-week price history of ITCI Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Intra-Cellular Therapies Inc’s current trading price is 0.68% away from its 52-week high, while its distance from the 52-week low is 87.85%. The stock’s price range during this period has spanned from $45.50 to $84.89. In the Healthcare sector, the Intra-Cellular Therapies Inc’s shares surpassed a trading volume of approximately 2.52 million for the day, which was noticeably higher compared to the average daily volume of 9.0.52 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Intra-Cellular Therapies Inc (ITCI) has experienced a quarterly rise of 8.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.03B and boasts a workforce of 610 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 74.65, with a change in price of +17.06. Similarly, Intra-Cellular Therapies Inc recorded 841,995 in trading volume during the last 100 days, posting a change of +24.94%.

Examining ITCI’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ITCI stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

ITCI Stock Stochastic Average

Today, Intra-Cellular Therapies Inc’s raw stochastic average for the past 50 days stands at 85.20%, indicating a rise from the raw stochastic average of the last 20 days, which was 85.20%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 74.26% and 66.64% respectively.

ITCI Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 19.34%. However, over the past six months, we’ve seen a weaker performance of 17.52%. The price of ITCI fallen by 17.65% over the last 30 days. And in the last five days, it has surged by 13.93%.

Most Popular